Cell biological characterization of the malaria vaccine candidate trophozoite exported protein 1

PLoS One. 2012;7(10):e46112. doi: 10.1371/journal.pone.0046112. Epub 2012 Oct 8.

Abstract

In a genome-wide screen for alpha-helical coiled coil motifs aiming at structurally defined vaccine candidates we identified PFF0165c. This protein is exported in the trophozoite stage and was named accordingly Trophozoite exported protein 1 (Tex1). In an extensive preclinical evaluation of its coiled coil peptides Tex1 was identified as promising novel malaria vaccine candidate providing the rational for a comprehensive cell biological characterization of Tex1. Antibodies generated against an intrinsically unstructured N-terminal region of Tex1 and against a coiled coil domain were used to investigate cytological localization, solubility and expression profile. Co-localization experiments revealed that Tex1 is exported across the parasitophorous vacuole membrane and located to Maurer's clefts. Change in location is accompanied by a change in solubility: from a soluble state within the parasite to a membrane-associated state after export to Maurer's clefts. No classical export motifs such as PEXEL, signal sequence/anchor or transmembrane domain was identified for Tex1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Antigens, Protozoan / genetics
  • Antigens, Protozoan / immunology*
  • Antigens, Protozoan / metabolism*
  • Base Sequence
  • Blotting, Western
  • Brefeldin A / pharmacology
  • Carrier Proteins / genetics
  • Carrier Proteins / metabolism
  • Cytosol / drug effects
  • Cytosol / metabolism
  • Erythrocytes / drug effects
  • Erythrocytes / metabolism
  • Erythrocytes / parasitology*
  • Gene Expression
  • Malaria / metabolism
  • Malaria / parasitology*
  • Malaria Vaccines / immunology
  • Membrane Proteins / genetics
  • Membrane Proteins / metabolism
  • Mice
  • Microscopy, Confocal
  • Molecular Sequence Data
  • Organelles / metabolism
  • Plasmodium falciparum / genetics
  • Plasmodium falciparum / immunology
  • Plasmodium falciparum / metabolism*
  • Protein Transport / drug effects
  • Protozoan Proteins / genetics
  • Protozoan Proteins / immunology
  • Protozoan Proteins / metabolism*
  • Rabbits
  • Reverse Transcriptase Polymerase Chain Reaction
  • Vacuoles / metabolism

Substances

  • Antigens, Protozoan
  • Carrier Proteins
  • MAHRP-1 protein, Plasmodium falciparum
  • Malaria Vaccines
  • Membrane Proteins
  • Pfsbp1 protein, Plasmodium falciparum
  • Protozoan Proteins
  • Tex1 protein, Plasmodium falciparum
  • Brefeldin A

Grants and funding

The project was supported by the Swiss National Science Foundation (http://www.snf.ch/) grant number 310030-112244, by the Novartis Stiftung für Medizinisch-Biologische Forschung (http://www.stiftungmedbiol.novartis.com/) and EMVI (http://www.emvi.org). This study was funded by the Novartis Stiftung für Medizinisch-Biologische Forschung (http://www.stiftungmedbiol.novartis.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.